Journal article

Prevalence of early initiation of breastfeeding and determinants of delayed initiation of breastfeeding: secondary analysis of the WHO Global Survey

Kenzo Takahashi, Togoobaatar Ganchimeg, Erika Ota, Joshua P Vogel, Joao Paulo Souza, Malinee Laopaiboon, Cynthia Pileggi Castro, Kapila Jayaratne, Eduardo Ortiz-Panozo, Pisake Lumbiganon, Rintaro Mori



Early initiation of breastfeeding (EIBF) within 1 hour of birth can decrease neonatal death. However, the prevalence of EIBF is approximately 50% in many developing countries, and data remains unavailable for some countries. We conducted a secondary analysis using the WHO Global Survey on Maternal and Perinatal Health to identify factors hampering EIBF. We described the coverage of EIBF among 373 health facilities for singleton neonates for whom breastfeeding was initiated after birth. Maternal and facility characteristics of EIBF were compared to those of breastfeeding >1 hour after birth, and multiple logistic regression analysis was performed. In total, 244,569 singleton live births witho..

View full abstract


Awarded by Ministry of Health, Labour and Welfare, Japan

Awarded by Grants-in-Aid for Scientific Research

Funding Acknowledgements

The authors thank all members of the WHO Global Survey on Maternal and Perinatal Health Research Network, including regional and country coordinators, data collection coordinators, facility coordinators, data collectors and all staff of the participating facilities who made the surveys possible. The views expressed in this article represent the views of the named authors only and not the views of their institutions or organisations. The WHO Global Survey on Maternal and Perinatal Health was funded by the Governments of China, India and Japan and the United States Agency for International Development (USAID). In addition, this secondary analysis is partially supported by the Health Labour Sciences Research Grant (Nos 26260101, 26200101) from the Ministry of Health, Labour and Welfare, Japan, and from the Japan Agency for Medical Research and Development (AMED). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.